{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:36:06Z","timestamp":1760888166816},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.transproceed.2007.04.021","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T14:02:02Z","timestamp":1198677722000},"page":"3098-3100","source":"Crossref","is-referenced-by-count":16,"title":["Posttransplantation Conversion to Sirolimus-Based Immunosuppression: A Single Center Experience"],"prefix":"10.1016","volume":"39","author":[{"given":"L.T. Santamaria","family":"Saber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Y.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2007.04.021_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.2610140102","article-title":"Rapamycin: a novel immunosuppressive macrolide","volume":"14","author":"Seghal","year":"1994","journal-title":"Med Res Rev"},{"key":"10.1016\/j.transproceed.2007.04.021_bib2","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties and mechanism of action","volume":"35","author":"Seghal","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.04.021_bib3","first-page":"SS5","article-title":"Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors","volume":"71","author":"Kreis","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.04.021_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2007.04.021_bib5","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2007.04.021_bib6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0041-1345(00)02396-4","article-title":"Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil","volume":"33","author":"McKane","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.04.021_bib7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/00007890-200105150-00017","article-title":"Multicenter trial exploring calcineurin inhibitor avoidance in renal transplantation","volume":"71","author":"Vincenti","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.04.021_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","article-title":"Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients","volume":"19","author":"Tierce","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2007.04.021_bib9","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2007.04.021_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/gfi336","article-title":"Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks","volume":"21","author":"Diekmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2007.04.021_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.arcmed.2005.12.003","article-title":"Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients","volume":"37","author":"Martinez-Mier","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.transproceed.2007.04.021_bib12","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","article-title":"Chronic renal allograft dysfunction","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2007.04.021_bib13","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200010270-00021","article-title":"Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience","volume":"70","author":"Dominguez","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.04.021_bib14","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1016\/S0041-1345(03)00240-9","article-title":"Conversion to sirolimus in solid organ transplantation: a single center experience","volume":"35","author":"Egidi","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2007.04.021_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1399-0012.2004.00314.x","article-title":"An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency","volume":"19","author":"Peddi","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2007.04.021_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1432-2277.2004.00032.x","article-title":"Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience","volume":"18","author":"Weber","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2007.04.021_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0012.2005.00329.x","article-title":"Rapamycin in patients with chronic renal allograft dysfunction","volume":"19","author":"Wu","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2007.04.021_bib18","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2007.04.021_bib19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.04.021_bib20","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507009566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507009566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T20:23:42Z","timestamp":1546374222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134507009566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0041134507009566"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2007.04.021","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}